355836-08-7 Usage
General Description
2,4-Dimethyl-6-methoxyphenylboronic Acid is a chemical compound often used in pharmaceuticals and scientific research. This organic compound is derived from boronic acid, and importantly, includes phenyl rings, methyl groups, and a methoxy group in its structure. Its molecular formula is C9H13BO3; it is relatively stable under ordinary conditions. Often used in Suzuki coupling processes, it plays a crucial role in the creation of more complex molecules used in drug synthesis. As a specialty chemistry compound, it is valuable in building block chemistry, frequently being applied in fields like medicinal chemistry, drug discovery, and chemical biology.
Check Digit Verification of cas no
The CAS Registry Mumber 355836-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,8,3 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 355836-08:
(8*3)+(7*5)+(6*5)+(5*8)+(4*3)+(3*6)+(2*0)+(1*8)=167
167 % 10 = 7
So 355836-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H13BO3/c1-6-4-7(2)9(10(11)12)8(5-6)13-3/h4-5,11-12H,1-3H3
355836-08-7Relevant articles and documents
NLRP3 INFLAMMASOME INHIBITORS
-
Paragraph 0710-0711, (2020/12/04)
The present invention relates to novel pyridazin-3-yl phenol compounds of Formula (I): wherein R1, R2, R3, R4, R5 and Z are defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammaso
2-Arylpyrimidines: Novel CRF-1 receptor antagonists
Yoon, Taeyoung,De Lombaert, Stephane,Brodbeck, Robbin,Gulianello, Michael,Krause, James E.,Hutchison, Alan,Horvath, Raymond F.,Ge, Ping,Kehne, John,Hoffman, Diane,Chandrasekhar, Jayaraman,Doller, Dario,Hodgetts, Kevin J.
scheme or table, p. 4486 - 4490 (2009/04/08)
The design, synthesis and structure-activity relationship studies of a novel series of CRF-1 receptor antagonists, the 2-arylpyrimidines, are described. The effects of substitution on the aromatic ring and the pyrimidine core on CRF-1 receptor binding wer
